Massachusetts-based Revvity, Inc. (RVTY) is a global life sciences and diagnostics company that provides instruments, reagents, software, and services to support drug discovery, clinical research, and medical diagnostics. Valued at $9.5 billion by market cap, the company focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection, diagnosis, informatics, and other areas. Companies worth $10 billion or more are generally described as “large-cap st ...